1832 Asset Management L.P. Astrazeneca PLC Transaction History
1832 Asset Management L.P.
- $55.8 Billion
- Q3 2024
A detailed history of 1832 Asset Management L.P. transactions in Astrazeneca PLC stock. As of the latest transaction made, 1832 Asset Management L.P. holds 26,528 shares of AZN stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,528
Previous 65,772
59.67%
Holding current value
$1.77 Million
Previous $5.13 Million
59.7%
% of portfolio
0.0%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding AZN
# of Institutions
1,349Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.19 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.8 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.48 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.45 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.27 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $206B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...